United States Surgical

Device companies large and small have failed repeatedly in efforts to address bifurcations, which remain one of the largest unmet opportunities in cardiology. Cappella thinks it can solve the problem

Whether single-port surgery or NOTES is the true next revolution in surgical procedures, TransEnterix believes it has the answer to both. By David Cassak Minimally invasive surgery, performed through

A look at recent exits challenges the widely held view that device investments have lower return potential than biotech investments. However, a close inspection at the risk:return profile reveals that

One of the most successful centers of medical device innovation, Israel is wrestling with that success and adopting new models to build on it. by David Cassak Over the past decade or so, Israel has cl